Clinical record
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Harker LA, Boissel JP, Pilgrim AJ, Gent M. Comparative safety and tolerability of clopidogrel and aspirin: results from CAPRIE. CAPRIE Steering Committee and Investigators. Clopidogrel versus aspirin in patients at risk of ischaemic events. Drug Saf 1999; 21: 325-335.
- 2. Beltran-Robles M, Marques Saavedra E, Sanchez-Muñoz D, Romero-Gomez M. Hepatotoxicity induced by clopidogrel. J Hepatol 2004; 40: 560-562.
- 3. Chau TN, Yim KF, Mok NS, et al. Clopidogrel-induced hepatotoxicity after percutaneous coronary stenting. Hong Kong Med J 2005; 11: 414-416.
- 4. Willens HJ. Clopidogrel-induced mixed hepatocellular and cholestatic liver injury. Am J Ther 2000; 7: 317-318.
- 5. Wolf I, Mouallem M, Rath S, Farfel Z. Clopidogrel-induced systemic inflammatory response syndrome. Mayo Clin Proc 2003; 78: 618-620.
- 6. Höllmüller I, Stadlmann S, Graziadei I, Vogel W. Clinico-histopathological characteristics of clopidogrel-induced hepatic injury: case report and review of literature. Eur J Gastroenterol Hepatol 2006; 18: 931-934.
Online responses are no longer available. Please refer to our instructions for authors page for more information.
None identified.